β1- and β1/β2-adrenergic receptor antagonists block 6-nitrodopamine-induced contractions of the rat isolated epididymal vas deferens

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  2022-07-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00210-022-02268-6PMID 35798982
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alpha1-adrenergic antagonists block 6-nitrodopamine contractions on the rat isolated epididymal vas deferens.

  2021cited by this paper
• 6-Nitrodopamine is released by human umbilical cord vessels and modulates vascular reactivity.

  2021cited by this paper
• Quantification of 6-nitrodopamine in Krebs-Henseleit's solution by LC-MS/MS for the assessment of its basal release from Chelonoidis carbonaria aortae in vitro.

  2021cited by this paper
• 6-Nitrodopamine is an endogenous mediator of rat isolated epididymal vas deferens contractions induced by electric-field stimulation.

  2021cited by this paper
• Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0

  2020cited by this paper
• Reporting animal research: Explanation and Elaboration for the ARRIVE guidelines 2019

  2019cited by this paper
• New Author Guidelines for Displaying Data and Reporting Data Analysis and Statistical Methods in Experimental Biology

  2019cited by this paper
• Common misconceptions about data analysis and statistics

  2014cited by this paper
• Common Misconceptions about Data Analysis and Statistics

  2014cited by this paper
• Vas deferens--a model used to establish sympathetic cotransmission.

  2010influential reference
• Once-Daily High-Dose Pindolol for Paroxetine-Refractory Premature Ejaculation: A Double-Blind, Placebo-Controlled and Randomized Study

  2008cited by this paper
• Interaction between voltage-gated sodium channels and the neurotoxin, tetrodotoxin

  2008cited by this paper
• Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers.

  2006cited by this paper
• Doxazosin in the treatment of benign prostatic hypertrophy: an update

  2006cited by this paper
• Terazosin in the Treatment of Premature Ejaculation: A Short-term Follow-up

  2005cited by this paper
• Terminal axons ensheathed in smooth muscle cells of the vas deferens

  2004cited by this paper
• State of the art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

  2004cited by this paper
• Tamsulosin

  2002cited by this paper
• Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction.

  2002cited by this paper
• β-Blocker Therapy and Symptoms of Depression, Fatigue, and Sexual Dysfunction

  2002cited by this paper
• S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.

  2001cited by this paper
• Tamsulosin: current clinical experience.

  2001cited by this paper
• Alpha blockers: are all created equal?

  2000cited by this paper
• An in vivo evaluation of the therapeutic potential of sympatholytic agents on premature ejaculation

  1999cited by this paper
• TTX-sensitive Na(+) and nifedipine-sensitive Ca(2+) channels in rat vas deferens smooth muscle cells.

  1999cited by this paper
• Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor Binding

  1999cited by this paper
• Sexual dysfunction related to antihypertensive agents: results from the animal model

  1999cited by this paper
• Tamsulosin 0.4 mg Once Daily: Effect on Sexual Function in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction

  1999cited by this paper
• in vivo.

  1999cited by this paper
• SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

  1997cited by this paper
• Tamsulosin

  1996cited by this paper
• Bioactive 6-Nitronorepinephrine Identified in Mammalian Brain*

  1996cited by this paper
• Alpha-1 blockade pharmacotherapy in primitive psychogenic premature ejaculation resistant to psychotherapy.

  1995cited by this paper
• Binding of antidepressants to human brain receptors: focus on newer generation compounds

  1994cited by this paper
• Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.

  1992cited by this paper
• Opposite effects of 5-methoxy-N,N-di-methyl-tryptamine and 5-hydroxytryptophan on male rat sexual behavior.

  1991cited by this paper
• The stereospecificity of LY253352 for α1‐adrenoceptor binding sites in the brain and prostate

  1988cited by this paper
• Terazosin: a new long-acting alpha 1-adrenergic antagonist for hypertension.

  1988cited by this paper
• Ejaculatory failure and urinary dysfunction secondary to labetalol.

  1988cited by this paper
• The stereospecificity of LY253352 for alpha 1-adrenoceptor binding sites in the brain and prostate.

  1988cited by this paper
• A double-blind controlled trial of a new alpha-1 blocking drug in the treatment of bladder outflow obstruction.

  1985cited by this paper
• Binding of agonists and antagonists to β-adrenoceptors in rat vas deferens: relationship to functional response

  1985cited by this paper
• Characterization of beta-adrenergic receptors in the rat vas deferens using [3H]-dihydroalprenolol binding.

  1983cited by this paper
• Characterization of β-adrenergic receptors in the rat vas deferens using [3H]-dihyroalprenolol binding

  1983cited by this paper
• A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.

  1982cited by this paper
• In vitro ACTIVITY OF RO363, A β1‐ADRENOCEPTOR SELECTIVE AGONIST

  1980cited by this paper
• In vitro activity of RO363, a beta1-adrenoceptor selective agonist.

  1980cited by this paper
• Evidence for the presence of β2-inhibitory adrenoceptors in the rat vas deferens

  1979cited by this paper
• Evidence for the presence of beta 2-inhibitory adrenoceptors in the rat vas deferens.

  1979cited by this paper
• Sexual Side-Effects of Clomipramine (Anafranil)

  1973cited by this paper
• Tetrodotoxin Derivatives: Chemical Structure and Blockage of Nerve Membrane Conductance

  1967cited by this paper

• Basal release of 6-cyanodopamine from rat isolated vas deferens and its role on the tissue contractility

  2024cites this paper
• 6-Nitrodopamine potentiates contractions of rat isolated vas deferens induced by noradrenaline, adrenaline, dopamine and electric field stimulation

  2023cites this paper
• Relaxation of thoracic aorta and pulmonary artery rings of marmosets (Callithrix spp.) by endothelium-derived 6-nitrodopamine

  2023cites this paper
• Alpha_1-adrenergic blockers selectively antagonize the contractions induced by 6-nitrodopamine in the human vas deferens

  2023cites this paper
• The pivotal role of neuronal nitric oxide synthase in the release of 6-nitrodopamine from mouse isolated vas deferens.

  2023cites this paper
• Measurement of 6-cyanodopamine, 6-nitrodopa, 6-nitrodopamine and 6-nitroadrenaline by LC-MS/MS in Krebs-Henseleit solution. Assessment of basal release from rabbit isolated right atrium and ventricles.

  2023cites this paper
• 6-NitroDopamine is an endogenous modulator of rat heart chronotropism.

  2022cites this paper